Cargando…
SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
Triple-negative subtype of breast cancer (TNBC) is hallmarked by frequent disease relapse and shows highest mortality rate. Although PD-1/PD-L1 immune checkpoint blockades have recently shown promising clinical benefits, the overall response rate remains largely insufficient. Hence, alternative ther...
Autores principales: | Hasmim, Meriem, Xiao, Malina, Van Moer, Kris, Kumar, Akinchan, Oniga, Alexandra, Mittelbronn, Michel, Duhem, Caroline, Chammout, Anwar, Berchem, Guy, Thiery, Jean Paul, Volpert, Marianna, Hollier, Brett, Noman, Muhammad Zaeem, Janji, Bassam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501677/ https://www.ncbi.nlm.nih.gov/pubmed/36159844 http://dx.doi.org/10.3389/fimmu.2022.982821 |
Ejemplares similares
-
Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer
por: Xiao, Malina, et al.
Publicado: (2021) -
Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
por: Noman, Muhammad Zaeem, et al.
Publicado: (2019) -
Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies
por: Xiao, Malina, et al.
Publicado: (2021) -
A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022) -
Firing up the cold tumors by targeting Vps34
por: Janji, Bassam, et al.
Publicado: (2020)